Dr. Welsh, installed as president during ACRO’s annual meeting in Washington, D.C., will serve a two-year term as president. In 2017, Dr. Welsh will transition to Chairman of the Board for ACRO.
ARCO is the essential professional society for success in the day-to-day practice of radiation oncology. It focuses on ensuring the highest quality of care for radiation therapy patients and promoting success in the practice of radiation oncology through education, responsible socioeconomic advocacy and integration of science and technology into clinical practice.
In addition to ACRO, Dr. Welsh has actively and extensively served in other professional organizations. Dr. Welsh recently concluded an eight-year term as advisor to the Nuclear Regulatory Commission’s Advisory Committee on the Medical Uses of Isotopes. He formerly served as chair of the Radiological Society of North America’s Radiation Oncology Scientific Program Subcommittee and as an alternate councilor in the American College of Radiology. Dr. Welsh held or holds several leadership positions within the American Society for Radiation Oncology.
Dr. Welsh is a professor, medical director and director of Clinical and Translational Research in the Department of Radiation Oncology of Loyola University Chicago Stritch School of Medicine. He also is chief of Radiation Oncology at Edward Hines Jr. VA Hospital. Dr. Welsh is a fellow of the American College of Radiation Oncology.
Dr. Welsh earned his medical degree from the State University of New York at Stony Brook and a master’s degree in molecular biophysics and biochemistry from Yale University. Dr. Welsh completed a residency in radiation oncology at Johns Hopkins Hospital and completed a fellowship in helical tomotherapy while at the University of Wisconsin-Madison.